Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-13 5:13 pm Purchase | 2023-12-31 | 13G | SQZ Biotechnologies Company SQZB | AMERICAN INTERNATIONAL GROUP INC. AIG | 2,517,173 8.500% | 2,265,456 (+900.00%) | Filing History |
2024-02-09 5:10 pm Purchase | 2023-12-31 | 13G | SQZ Biotechnologies Company SQZB | Artal International S.C.A. | 1,141,309 3.900% | 980,678 (+610.52%) | Filing History |
2023-02-14 2:25 pm Sale | 2022-12-31 | 13G | SQZ Biotechnologies Company SQZB | 683 Capital Management LLC | 133,089 4.500% | -52,125 (-28.14%) | Filing History |
2023-02-14 07:55 am Sale | 2022-12-31 | 13G | SQZ Biotechnologies Company SQZB | AMERICAN INTERNATIONAL GROUP INC. AIG | 251,717 8.500% | -1,210 (-0.48%) | Filing History |
2023-02-14 06:13 am Unchanged | 2022-12-31 | 13G | SQZ Biotechnologies Company SQZB | NanoDimension II Management Ltd | 144,522 4.900% | 0 (Unchanged) | Filing History |
2023-02-10 7:53 pm Purchase | 2022-12-31 | 13G | SQZ Biotechnologies Company SQZB | Artal International S.C.A. | 160,631 5.500% | 160,631 (New Position) | Filing History |
2022-02-14 3:51 pm Purchase | 2021-12-31 | 13G | SQZ Biotechnologies Company SQZB | AMERICAN INTERNATIONAL GROUP INC. AIG | 252,927 9.000% | 28,131 (+12.51%) | Filing History |
2022-02-14 06:32 am Purchase | 2021-12-31 | 13G | SQZ Biotechnologies Company SQZB | Temasek Holdings (Private) Ltd | 275,817 9.800% | 24,425 (+9.72%) | Filing History |
2022-02-11 6:47 pm Purchase | 2021-12-31 | 13G | SQZ Biotechnologies Company SQZB | 683 Capital Management LLC | 185,214 6.600% | 27,405 (+17.37%) | Filing History |
2022-02-11 5:12 pm Purchase | 2021-12-31 | 13D | SQZ Biotechnologies Company SQZB | Polaris Management Co. VII L.L.C. | 322,691 11.400% | 1,605 (+0.50%) | Filing History |
2022-02-10 4:08 pm Sale | 2021-12-31 | 13G | SQZ Biotechnologies Company SQZB | NanoDimension II Management Ltd | 144,522 5.100% | -3,875 (-2.61%) | Filing History |
2022-02-09 5:22 pm Sale | 2022-01-31 | 13G | SQZ Biotechnologies Company SQZB | BlackRock Inc. BLK | 140,200 4.990% | -1,188 (-0.84%) | Filing History |
2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | SQZ Biotechnologies Company SQZB | BlackRock Inc. BLK | 141,387 5.000% | 141,387 (New Position) | Filing History |
2021-08-09 4:59 pm Purchase | 2021-07-29 | 13G | SQZ Biotechnologies Company SQZB | 683 Capital Management LLC | 157,809 5.600% | 157,809 (New Position) | Filing History |
2021-02-18 5:36 pm Purchase | 2020-12-31 | 13G | SQZ Biotechnologies Company SQZB | NanoDimension II Management Ltd | 148,397 6.000% | 148,397 (New Position) | Filing History |
2021-02-16 3:19 pm Purchase | 2020-12-31 | 13G | SQZ Biotechnologies Company SQZB | AMERICAN INTERNATIONAL GROUP INC. AIG | 224,797 9.100% | 224,797 (New Position) | Filing History |
2021-02-12 9:20 pm Unchanged | 2020-12-31 | 13G | SQZ Biotechnologies Company SQZB | Invus Public Equities L.P. | 160,631 6.500% | 0 (Unchanged) | Filing History |
2020-11-13 5:03 pm Purchase | 2020-11-03 | 13D | SQZ Biotechnologies Company SQZB | Polaris Management Co. VII L.L.C. | 321,086 13.400% | 321,086 (New Position) | Filing History |
2020-11-13 4:54 pm Purchase | 2020-11-03 | 13G | SQZ Biotechnologies Company SQZB | Temasek Holdings (Private) Ltd | 251,392 10.500% | 251,392 (New Position) | Filing History |
2020-11-13 4:51 pm Purchase | 2020-11-03 | 13G | SQZ Biotechnologies Company SQZB | Invus Public Equities L.P. | 160,631 6.500% | 160,631 (New Position) | Filing History |